0 followers
Promontory Therapeutics Inc. is a clinical stage pharmaceutical company developing small molecule immunotherapies. The company's lead candidate, PT-112, is a novel chemical entity under clinical development that exhibits a unique combination of properties, including immunogenic cell death as well as... Read more
Matthew Price
HistoSonics
3 followers
Rocket Pharmaceuticals
2 followers
AbbVie
207 followers
Myonex
1 follower
Mineralys Therapeutics
1 follower
Odyssey Therapeutics
2 followers
Amgen
238 followers
PTC Therapeutics
11 followers
Bristol-Myers Squibb
215 followers
Thermo Fisher Scientific
184 followers
Genentech
164 followers
Explore companies